DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.
about
The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.Measurement of Residual Disease in Acute Myeloid Leukemia.Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectivesBiological and clinical influences of in acute myeloid leukemia patients with mutations
P2860
Q47804815-859C443B-E525-4256-B3DA-0BF16F342EDCQ50075132-FFCD66B4-A53E-484B-BDC5-13AD1DEA39A3Q52689074-3AA5C845-AB68-4F38-8C42-B003AE03AEC4Q55009819-8990DB18-30A8-4A6E-9B06-B2FAD179964DQ55279705-A39BEBD9-1AAB-44E4-9EFF-020482E7A403Q57176232-AA220B8E-039E-4C2F-9063-39C708FA5281Q58797413-9C9FA907-7223-4878-BEB6-425D4303822D
P2860
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@en
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@nl
type
label
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@en
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@nl
prefLabel
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@en
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
DNMT3A mutant transcript level ...... s with acute myeloid leukemia.
@en
P2093
A Corbacioglu
A Kaumanns
B Schlegelberger
German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
P2860
P2888
P356
10.1038/LEU.2017.200
P577
2017-06-23T00:00:00Z